Deep Track Capital’s Passage Bio PASG Stock Holding History

Deep Track Capital’s Portfolio PASG Stock Details PASG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-71,953	Closed	-$1.8M	–	70
2022 Q3	$1.8M	Sell	71,953 -44,047	-38%	-$1.74M	0.08%	64
2022 Q2	$5.47M	Sell	116,000 -52,750	-31%	-$2.46M	0.36%	44
2022 Q1	$10.5M	Buy	168,750 +7,900	+5%	+$651K	0.67%	37
2021 Q4	$20.4M	Buy	+160,850	New	+$26.3M	1.44%	29

Other funds holding PASG

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Deep Track Capital's PASG Position: Q4 2022 in Review

Deep Track Capital sold out of Passage Bio (PASG) in Q4 2022, closing a stake of 71,953 shares — an estimated $1.8M sold.

Deep Track Capital first reported a position in PASG in Q4 2021 and held it in 4 quarters. The position peaked at $20.4M in Q4 2021. 66 funds tracked by Wall St. Rank hold PASG as of Q4 2022.

Deep Track Capital reported no remaining Passage Bio position as of Q4 2022 after selling out during the quarter.
Deep Track Capital sold 71,953 Passage Bio shares in Q4 2022, an estimated $1.8M.
Deep Track Capital first reported a position in Passage Bio in Q4 2021 and held it in 4 quarters.
Deep Track Capital's Passage Bio position peaked at $20.4M in Q4 2021.
66 funds tracked by Wall St. Rank held Passage Bio as of Q4 2022.

Based on Deep Track Capital's 13F filing for Q4 2022, filed 14 Feb 2023.